INS and type 2 diabetes mellitus: The combination of empagliflozin and liraglutide reduced central systolic blood pressure, perfused boundary region, and arterial stiffness in patients with T2DM to a greater extent than insulin in addition to similar glycemic effects, suggesting that the combination should be preferred over traditional insulin plus metformin in patients with T2DM and high cardiovascular risk [51].